NLRP3 and metabolic dysfunction-associated steatotic liver disease: In fact, some evidence indicates that genetic deficiency of the inflammasomes NLRP3 and NLRP6 promotes NAFLD/NASH progression by inducing intestinal microbiota dysbiosis and liver accumulation of abnormal bacterial products via portal circulation [186].